Financial Highlights | Lee's Pharmaceutical

Financial Highlights

For the year ended 31 December
HK$'000
2023
2022
Change
Revenue
1,053,034
1,233,148
-14.6%
Gross Profit
551,311
770,755
-28.5%
Gross Profit Margin (%)
52.4%
62.5%
-10.1%
EBITDA
179,680
213,992
-16.0%
Profit from Operations
43,553
76,560
-43.1%
Profit attributable to shareholders of the Company
16,698
51,284
-67.4%
Equity attributable to the owners of the Company
2,038,955
1,924,107
+5.97%
Basic EPS
HK 2.84 cents
HK 8.71 cents
-67.4%
Diluted EPS
HK 2.84 cents
HK 8.71 cents
-67.4%
Total Dividend per Share (Interim + Final)
HK 1.80 cents
HK 2.00 cents
-10.0%